MITNF yields 1.26% · JNJ yields 2.13%● Live data
📍 MITNF pulled ahead of the other in Year 1
Combined, MITNF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of MITNF + JNJ for your $10,000?
Mi Technovation Berhad, an investment holding company, designs, develops, manufactures, and sells wafer level chip scale packaging (WLCSP) sorting machines for the semiconductor industry in Southeast Asia, Northeast Asia, and North Atlantic. The company operates through three segments: Semiconductor Equipment Business Unit, Semiconductor Material Business Unit, and Others. It offers Mi series product for advanced packaging and die sorting tape and reel machine with vision inspection for smartphones, tablets, wireless wearable devices, Bluetooth, near field sensing, and sensor applications; and Vi series product for wafer and package inspection in 2D and 3D mode for telecommunication and IoT industries. The company also provides Ai series product, a precision bonding machine for extra fine pitch with think die and substrate thickness used in server in telecommunications industry, GPU and CPU for high performance computing application in AI and blockchain, and image sensor and memory applications; and Si series, a final test equipment for high power and fine pitch devices used in electric vehicles and telecommunications applications. It is also involved in the provision of maintenance services and technical support for its machines; sale of related spare parts and components; and manufacture and sale of solder spheres and other semiconductor-related materials. The company was formerly known as Mi Equipment Holdings Berhad and changed its name to Mi Technovation Berhad in December 2018. Mi Technovation Berhad was founded in 2007 and is headquartered in Bayan Lepas, Malaysia.
Full MITNF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.